Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (561-570 of 662) with videos related to

Pageof 67
Sort By:
Hemasphere|April 25, 2025
Comparing functional and genomic-based precision medicine in blood cancer patientsLukas Kazianka, Alexander Pichler, Christiane Agreiter, et al.
Frontiers in Veterinary Science|December 27, 2021
Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus ProposalMichael Willmann, Vilma Yuzbasiyan-Gurkan, Laura Marconato, et al.
Acta Dermato-Venereologica|December 24, 2015
Multidisciplinary Management of Mastocytosis: Nordic Expert Group ConsensusSigurd Broesby-Olsen, Ingunn Dybedal, Theo Gülen, et al.
Wiener Klinische Wochenschrift|June 9, 2005
The European Competence Network on Mastocytosis (ECNM)Peter Valent, Michel Arock, Stephan C Bischoff, et al.
The Journal of Allergy and Clinical Immunology|June 8, 2024
Mast cell activation syndrome: Current understanding and research needsMariana Castells, Matthew P Giannetti, Matthew J Hamilton, et al.
Blood|April 29, 2020
CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemiaJohannes Schmoellerl, Inês Amorim Monteiro Barbosa, Thomas Eder, et al.
Leukemia|January 13, 2019
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosisMohamad Jawhar, Konstanze Döhner, Sebastian Kreil, et al.
Theranostics|September 15, 2020
Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine conceptsPeter Valent, Cem Akin, Karin Hartmann, et al.
The Journal of Allergy and Clinical Immunology|June 21, 2020
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinionsPeter Valent, Cem Akin, Patrizia Bonadonna, et al.
Leukemia|September 6, 2023
CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDSKarin Bauer, Sigrid Machherndl-Spandl, Lukas Kazianka, et al.
Pageof 67

Showing results (561-570 of 662) with videos related to

Sort By:
Pageof 67
Hemasphere|April 25, 2025
Comparing functional and genomic-based precision medicine in blood cancer patientsLukas Kazianka, Alexander Pichler, Christiane Agreiter, et al.
Frontiers in Veterinary Science|December 27, 2021
Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus ProposalMichael Willmann, Vilma Yuzbasiyan-Gurkan, Laura Marconato, et al.
Acta Dermato-Venereologica|December 24, 2015
Multidisciplinary Management of Mastocytosis: Nordic Expert Group ConsensusSigurd Broesby-Olsen, Ingunn Dybedal, Theo Gülen, et al.
Wiener Klinische Wochenschrift|June 9, 2005
The European Competence Network on Mastocytosis (ECNM)Peter Valent, Michel Arock, Stephan C Bischoff, et al.
The Journal of Allergy and Clinical Immunology|June 8, 2024
Mast cell activation syndrome: Current understanding and research needsMariana Castells, Matthew P Giannetti, Matthew J Hamilton, et al.
Blood|April 29, 2020
CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemiaJohannes Schmoellerl, Inês Amorim Monteiro Barbosa, Thomas Eder, et al.
Leukemia|January 13, 2019
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosisMohamad Jawhar, Konstanze Döhner, Sebastian Kreil, et al.
Theranostics|September 15, 2020
Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine conceptsPeter Valent, Cem Akin, Karin Hartmann, et al.
The Journal of Allergy and Clinical Immunology|June 21, 2020
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinionsPeter Valent, Cem Akin, Patrizia Bonadonna, et al.
Leukemia|September 6, 2023
CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDSKarin Bauer, Sigrid Machherndl-Spandl, Lukas Kazianka, et al.
Pageof 67